Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2018, Article ID 8264208, 12 pages
https://doi.org/10.1155/2018/8264208
Research Article

Biodistribution and Tumors MRI Contrast Enhancement of Magnetic Nanocubes, Nanoclusters, and Nanorods in Multiple Mice Models

1National University of Science and Technology (MISIS), Moscow 119049, Russia
2M.V. Lomonosov Moscow State University, Moscow 119991, Russia
3Department of Medical Nanobiotechnology, Russian National Research Medical University, Moscow 117997, Russia
4D. Mendeleev University of Chemical Technology of Russia, Moscow 125047, Russia

Correspondence should be addressed to V. Naumenko; moc.liamg@tciv.oknemuan

Received 11 July 2018; Accepted 19 August 2018; Published 24 September 2018

Academic Editor: Guillermina Ferro-Flores

Copyright © 2018 V. Naumenko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Nakamura, A. Mochida, P. L. Choyke, and H. Kobayashil, “Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?” Bioconjugate Chemistry, vol. 27, no. 10, pp. 2225–2238, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Maeda, Enhanced Permeability and Retention (EPR) Effect: Basis for Drug Targeting to Tumor, Biomedical Aspects of Drug Targeting, Springer US, Boston, MA, USA, 2002.
  3. L. Hajba and A. Guttman, “The use of magnetic nanoparticles in cancer theranostics: toward handheld diagnostic devices,” Biotechnology Advances, vol. 34, no. 4, pp. 354–361, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Arami, A. P. Khandhar, and A. Tomitaka, “In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agents,” Biomaterials, vol. 52, pp. 251–261, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. R. K. Ramanathan, R. L. Korn, and N. Raghunand, “Correlation between ferumoxytol uptake in tumor lesions by MRI and response to nanoliposomal irinotecan in patients with advanced solid tumors: a pilot study,” Clinical Cancer Research, vol. 23, no. 14, pp. 3638–3648, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Miller, S. Gadde, C. Pfirschke et al., “Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle,” Science Translational Medicine, vol. 7, no. 314, p. 314, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. B. H. Kim, N. Lee, H. Kim et al., “Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents,” Journal of the American Chemical Society, vol. 133, no. 32, pp. 12624–12631, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Y.-X. J. Wang, “Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application,” Quantitative Imaging in Medicine and Surgery, vol. 1, no. 1, pp. 35–40, 2011. View at Publisher · View at Google Scholar
  9. L. Lartigue, P. Hugounenq, D. Alloyeau et al., “Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents,” ACS Nano, vol. 6, no. 12, pp. 10935–10949, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kostopoulou, S. K. P. Velu, K. Thangavel et al., “Colloidal assemblies of oriented maghemite nanocrystals and their NMR relaxometric properties,” Dalton Transaction, vol. 43, no. 22, pp. 8395–8404, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Arami, A. Khandhar, D. Liggitt, and K. M. Krishnan, “In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles,” Chemical Society Reviews, vol. 44, no. 23, pp. 8576–8607, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Wu, Y. Tan, H. Mao, and M. Zhang, “Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells,” International Journal of Nanomedicine, vol. 5, pp. 385–399, 2010. View at Publisher · View at Google Scholar
  13. T. R. Pisanic, J. D. Blackwell, V. I. Shubayev, R. R. Fiñones, and S. Jin, “Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,” Biomaterials, vol. 28, no. 16, pp. 2572–2581, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. R. L. de Freitas, P. R. O. Soares, R. de Paula Santos et al., “In vitro biological activities of anionic gamma-Fe2O3 nanoparticles on human melanoma cells,” Journal of Nanoscience and Nanotechnology, vol. 8, no. 5, pp. 2385–2391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Tong, S. Hou, Z. Zheng, J. Zhou, and G. Bao, “Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity,” Nano Letters, vol. 10, no. 11, pp. 4607–4613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Yang, H. Kuang, W. Zhang et al., “Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice,” Nanoscale, vol. 7, no. 2, pp. 625–636, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Wilhelm, A. J. Tavares, Q. Dai et al., “Analysis of nanoparticle delivery to tumours,” Nature Reviews Materials, vol. 1, no. 5, p. 16014, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. J. E. Rosen, L. Chan, D.-B. Shieh, and F. X. Gu, “Iron oxide nanoparticles for targeted cancer imaging and diagnostics,” Nanomedicine: Nanotechnology, Biology and Medicine, vol. 8, no. 3, pp. 275–290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. J. Soenen, P. Rivera-Gil, J.-M. Montenegro, W. J. Parak, S. C. De Smedt, and K. Braeckmans, “Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation,” Nano Today, vol. 6, no. 5, pp. 446–465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. Arnida Janát-Amsbury, A. Ray, C. M. Peterson, and H. Ghandehari, “Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 77, no. 3, pp. 417–423, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-H. Park, G. von Maltzahn, L. Zhang et al., “Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting,” Small, vol. 5, no. 6, pp. 694–700, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Zhan, G. Yanxia, Z. Xiaoyong et al., “Biodistribution of co-exposure to multi-walled carbon nanotubes and graphene oxide nanoplatelets radiotracers,” Journal of Nanoparticle Research, vol. 13, no. 7, pp. 2939–2947, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-T. Yang, J. Luo, Q. Zhou, and H. Wang, “Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes,” Theranostics, vol. 2, no. 3, pp. 271–282, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-H. Park, G. von Maltzahn, and L. Zhang, “Magnetic iron oxide nanoworms for tumor targeting and imaging,” Advanced Materials, vol. 20, no. 9, pp. 1630–1635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. S. Aaron, A. C. Greene, P. G. Kotula, G. D. Bachand, and J. A. Timlin, “Advanced optical imaging reveals the dependence of particle geometry on interactions between CdSe quantum dots and immune cells,” Small, vol. 7, no. 3, pp. 334–341, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Qiu, Y. Liu, L. Wang et al., “Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods,” Biomaterials, vol. 31, no. 30, pp. 7606–7619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. L. Campbell, J. Arora, S. F. Cowell et al., “Quasi-cubic magnetite/silica core-shell nanoparticles as enhanced MRI contrast agents for cancer imaging,” PLoS One, vol. 6, no. 7, Article ID e21857, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Xu, G. Friedman, K. D. Humfeld, S. A. Majetich, and S. A. Asher, Synthesis and Utilization of Monodisperse Superparamagnetic Colloidal Particles for Magnetically Controllable Photonic Crystals, American Chemical Society, Washington, DC, USA, 2001.
  29. A. Kostopoulou and A. Lappas, “Colloidal magnetic nanocrystal clusters: variable length-scale interaction mechanisms, synergetic functionalities and technological advantages,” Nanotechnology Reviews, vol. 4, no. 6, pp. 595–624, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. B. A. Larsen, M. A. Haag, N. J. Serkova, K. R. Shroyer, and C.R. Stoldt, “Controlled aggregation of superparamagnetic iron oxide nanoparticles for the development of molecular magnetic resonance imaging probes,” Nanotechnology, vol. 19, no. 26, Article ID 265102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Sherwood, M. Rich, K. Lovas, J. Warram, M. S. Bolding, and Y. Bao, “T1-enhanced MRI-visible nanoclusters for imaging-guided drug delivery,” Nanoscale, vol. 9, no. 32, pp. 11785–11792, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Mikhaylov, U. Mikac, A. A. Magaeva et al., “Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment,” Nature Nanotechnology, vol. 6, no. 9, pp. 594–602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Venkataraman, J. L. Hedrick, Z. Y. Ong et al., “The effects of polymeric nanostructure shape on drug delivery,” Advanced Drug Delivery Reviews, vol. 63, no. 14-15, pp. 1228–1246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. E. V. Batrakova and A. V. Kabanov, “Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers,” Journal of Controlled Release, vol. 130, no. 2, pp. 98–106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. T. K. Jain, M. K. Reddy, M. A. Morales, D. L. Leslie-Pelecky, and V. Labhasetwar, “Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats,” Molecular Pharmaceutics, vol. 5, no. 2, pp. 316–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. W. Jones, R. A. Roberts, G. R. Robbins et al., “Nanoparticle clearance is governed by Th1/Th2 immunity and strain background,” Journal of Clinical Investigation, vol. 123, no. 7, pp. 3061–3073, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Yamashita and M. Hashida, “Pharmacokinetic considerations for targeted drug delivery,” Advanced Drug Delivery Reviews, vol. 65, no. 1, pp. 139–147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. A. Nikitin, I. V. Shchetinin, N. Y. Tabachkova et al., “Synthesis of iron oxide nanoclusters by thermal decomposition,” Langmuir, vol. 34, no. 15, pp. 4640–4650, 2018. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Nikitin, M. Fedorova, V. Naumenko et al., “Synthesis, characterization and MRI application of magnetite water-soluble cubic nanoparticles,” Journal of Magnetism and Magnetic Materials, vol. 441, pp. 6–13, 2017. View at Publisher · View at Google Scholar · View at Scopus
  40. K. C. L. Black, Y. Wang, H. P. Luehmann et al., “Radioactive 198 Au-doped nanostructures with different shapes for In Vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution,” ACS Nano, vol. 8, no. 5, pp. 4385–4394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. M. S. H. Akash and K. Rehman, “Recent progress in biomedical applications of pluronic (PF127): pharmaceutical perspectives,” Journal of Controlled Release, vol. 209, pp. 120–138, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Ranganathan, S. Madanmohan, A. Kesavan et al., “Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications,” International Journal of Nanomedicine, vol. 7, pp. 1043–1060, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. P. Melancon, W. Lu, and C. Li, “Gold-based magneto/optical nanostructures: challenges for in vivo applications in cancer diagnostics and therapy,” MRS Bulletin, vol. 34, no. 6, pp. 415–421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Albanese, P. S. Tang, and W. C. W. Chan, “The effect of nanoparticle size, shape, and surface chemistry on biological systems,” Annual Review of Biomedical Engineering, vol. 14, no. 1, pp. 1–16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Cho, A. Cervadoro, M. Ramirez et al., “Assembly of iron oxide nanocubes for enhanced cancer hyperthermia and magnetic resonance imaging,” Nanomaterials, vol. 7, no. 4, p. 72, 2017. View at Publisher · View at Google Scholar · View at Scopus
  46. F. M. Kievit, Z. R. Stephen, O. Veiseh et al., “Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs,” ACS Nano, vol. 6, no. 3, pp. 2591–2601, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Xu, L. Cheng, C. Wang, X. Ma, Y. Li, and Z. Liu, “Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery,” Biomaterials, vol. 32, no. 35, pp. 9364–9373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. S. B. Chaves, L. M. Lacava, Z. G. M. Lacava et al., “Light microscopy and magnetic resonance characterization of a DMSA-coated magnetic fluid in mice,” IEEE Transactions on Magnetics, vol. 38, no. 5, pp. 3231–3233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Mejías, S. Pérez-Yagüe, L. Gutiérrez et al., “Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy,” Biomaterials, vol. 32, no. 11, pp. 2938–2952, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Muro, C. Garnacho, J. A. Champion et al., “Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers,” Molecular Therapy, vol. 16, no. 8, pp. 1450–1458, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. S. Kim, T.-J. Yoon, K. Nam Yu et al., “Toxicity and tissue distribution of magnetic nanoparticles in mice,” Toxicological Sciences, vol. 89, no. 1, pp. 338–347, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Gu, R. H. Fang, M. J. Sailor, and J.-H. Park, “In Vivo clearance and toxicity of monodisperse iron oxide nanocrystals,” ACS Nano, vol. 6, no. 6, pp. 4947–4954, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Zanganeh, G. Hutter, R. Spitler et al., “Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues,” Nature Nanotechnology, vol. 11, no. 11, pp. 986–994, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Ittrich, K. Peldschus, N. Raabe, M. Kaul, and G. Adam, “Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy,” RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, vol. 185, no. 12, pp. 1149–1166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Weissleder, D. D. Stark, B. L. Engelstad et al., “Superparamagnetic iron oxide: pharmacokinetics and toxicity,” American Journal of Roentgenology, vol. 152, no. 1, pp. 167–173, 1989. View at Publisher · View at Google Scholar · View at Scopus